Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha Zhao

Showing results (321-330 of 380) with videos related to

Pageof 38
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2016
[Expression Profile of lncRNA NONHSAT040475 in Peripheral Blood Leukocytes of Healthy Persons]Fei-Yan Wang, Lan Luo, Sha-Sha Zhao, et al.
Human Pathology|June 21, 2011
Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese casesChang-li Lu, Yuan Tang, Qun-pei Yang, et al.
Magnetic Resonance in Medicine|May 26, 2009
Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter mapsChris J Rose, Samantha J Mills, James P B O'Connor, et al.
The Journal of Biological Chemistry|January 21, 2012
RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathwayShuo Shi, Yue-Zhen Deng, Jiang-Sha Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790MSha Zhao, Xuefei Li, Chao Zhao, et al.
International Journal of Cancer|February 21, 2019
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapiesYijun Jia, Xuefei Li, Tao Jiang, et al.
Cancer|March 28, 2017
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancerLimin Zhang, Tao Jiang, Xuefei Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Uncommon <i>EGFR</i> mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapyJinpeng Shi, Hui Yang, Tao Jiang, et al.
Journal of Healthcare Engineering|October 8, 2021
mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung CancerPeixin Chen, Shengyu Wu, Jia Yu, et al.
Journal of Diabetes Research|October 30, 2024
Impact of Vitamin E Supplementation on High-Density Lipoprotein in Patients With Haptoglobin Genotype-Stratified Diabetes: A Systematic Review of Randomized Controlled TrialsPan-Pan Zheng, Li-Wen Zhang, Dan Sheng, et al.
Pageof 38

Showing results (321-330 of 380) with videos related to

Sort By:
Pageof 38
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2016
[Expression Profile of lncRNA NONHSAT040475 in Peripheral Blood Leukocytes of Healthy Persons]Fei-Yan Wang, Lan Luo, Sha-Sha Zhao, et al.
Human Pathology|June 21, 2011
Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese casesChang-li Lu, Yuan Tang, Qun-pei Yang, et al.
Magnetic Resonance in Medicine|May 26, 2009
Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter mapsChris J Rose, Samantha J Mills, James P B O'Connor, et al.
The Journal of Biological Chemistry|January 21, 2012
RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathwayShuo Shi, Yue-Zhen Deng, Jiang-Sha Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790MSha Zhao, Xuefei Li, Chao Zhao, et al.
International Journal of Cancer|February 21, 2019
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapiesYijun Jia, Xuefei Li, Tao Jiang, et al.
Cancer|March 28, 2017
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancerLimin Zhang, Tao Jiang, Xuefei Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Uncommon <i>EGFR</i> mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapyJinpeng Shi, Hui Yang, Tao Jiang, et al.
Journal of Healthcare Engineering|October 8, 2021
mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung CancerPeixin Chen, Shengyu Wu, Jia Yu, et al.
Journal of Diabetes Research|October 30, 2024
Impact of Vitamin E Supplementation on High-Density Lipoprotein in Patients With Haptoglobin Genotype-Stratified Diabetes: A Systematic Review of Randomized Controlled TrialsPan-Pan Zheng, Li-Wen Zhang, Dan Sheng, et al.
Pageof 38